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1. Introduction
   Significant differences exist in the prevalence of enteric 
infections including Helicobacter pylori (H. pylori) in the hot 
and humid tropics in comparison to the colder temperate 
countries[1]. Several infective agents are found only in 
tropical countries[2]. Enteric infections (by coliforms, 
Vibrio, Salmonella, etc.) and colonization of H. pylori may 
be the greatest cause of all gastrointestinal problems in 
this region. In spite of mucosal immunity of the tropical 
people there is a heavy burden of enteric infection on them. 
These infections and their resistance to several drugs are 
a cause of concern in tropical Asia[3]. Extremely limited 
antimicrobial options as well as inadequate empirical 
antimicrobial treatment coupled to poor public health 
infrastructure to combat infections plays a major role in the 
menace[4]. The scientific community is constantly exploring 
all possible means to address the issue of enteric infection 
in the tropical countries. In this background plant based 
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novel antimicrobials directed against enteric pathogens may 
be of high solicitation.
   Dillenia pentagyna Roxb. (D. pentagyna, DP) has long 
been used in Indian traditional medicine for several ailments 
including dysentery. It is among several other plants that 
is yet to be fully explored for therapeutic potential. It is 
a flowering plant of the family Dilleniaceae, sometimes 
referred as Nagkeshar. The genus Dillenia has about 100 
species of flowering plants in the tropical and subtropical 
regions. Traditional knowledge about therapeutic value of 
D. pentagyna is substantial[5,6]. In India, the plant is spread 
across southern, central as well as north eastern states[7]. 
Though some antimicrobial and antitumour activity of D. 
pentagyna extract has been studied[8], more studies are 
required to understand its complete therapeutic prospective.
   In this preliminary work, three different fractions of 
D. pentagyna fruit extracts were screened for in vitro 
activity against municipal sewage microflora, a possible 
gastrointestinal pathogen load. Untreated municipal 
sewage of a Northeast Indian town was cultured and used 
for antimicrobial assay of the D. pentagyna fruit extracts. 
Several coliforms such as enterohemorrhagic Escherichia 
coli, Salmonella, Vibrio, etc. generally have high prevalence 
in municipal sewage[9-11]. Municipal sewage may even be a 
reservoir of antibiotic-resistant water bourne pathogens[12]. 
Transmission of H. pylori is also proposed via this route (by 
municipal sewage) to human[13]. Therefore, a bacterial stock 
cultured with municipal sewage may be a source of various 
enteric pathogens.
   Inhibition of urease by D. pentagyna fruit extracts 
was also studied. It is known that urease activity is the 
pathogenic factor of H. pylori since urease is essential for 
the colonization of and survival of H. pylori at very acidic pH 
of stomach[14,15]. Urease inhibition is, therefore, a strategy to 
combat H. pylori.
   Urease (urea amidohydrolase; EC 3.5.1.5) catalyzes 
hydrolysis of urea to ammonia and carbamate, the final 
step of nitrogen metabolism in living organisms such as H. 
pylori[16]. Ammonia, of such decomposing reactions diffuses 
across the cytoplasmic membrane, buffering the periplasmic 
space and allows growth in the presence of extracellular 
gastric acid and responsible for negative effects of urease 
activity in human health[17,18]. H. pylori is a Gram-negative 
bacterium that infects up to 50% of the world’s human 
population by colonizes the human gastric mucosa, leading 
to chronic gastritis, peptic ulcer and mucosa-associated 
lymphoid tissue lymphoma[19,20].
   Though effective therapy exists for enteric infections 
and H. pylori colonization, there are some drawbacks of 
the regimen. In the developing world, the major hurdles 
with conventional management have been the increasing 
antibiotic resistance, toxicity and side effects as well as 
significant cost of therapy[21,22]. Lack of patient compliance 
to the dosage schedules may be another factor that augments 
trouble.
   In order to search for a natural remedy for various enteric 
pathogens including H. pylori encountered by tropical 
people, this study may throw some light on therapeutic 
potential of D. pentagyna. 
   In future, isolation of pure compound/s from the active 
fraction and deduction of structure and antimicrobial 
po tent ia l  agains t  c l in ica l  i so la tes  i s  in tended. 
Gastrointestinal pathogens and H. pylori from gastric biopsy 
samples will be used. IC50 or MIC (minimum inhibitory 
concentration) estimation followed by 3D-QSAR and its 
inhibition kinetics against urease coupled to quantum 
polarized ligand docking with the Ni-bound metalloenzyme 
urease may reveal its drugability leading to a clinical trial 
pipeline.
2. Materials and methods
   Three different fractions of D. pentagyna fruit extracts 
were collected. Extracts are screened for their antimicrobial 
activity. The fraction with highest activity was studied for in 
vitro urease inhibition potential.
2.1. Isolation of fractions from D. pentagyna fruit 
   The powdered D. pentagyna fruits were defatted with 
petroleum ether (bp. 60-80 °C) and then extracted separately 
with aqueous (10%) methanol through percolation at room 
temperature (48 h) followed by at an elevated temperature 
using Soxhlet extractor. The mixed extract was filtered 
through Whatmann filter paper No.1 and then concentrated 
under reduced pressure yielding the crude extract as 
gummy residue (700 g). The crude extract was then treated 
with 200 mL distilled water, defatted with petroleum ether 
and extracted successively with chloroform, ethyl acetate 
and n-butanol (5 mL伊50 mL for each solvent) and then dried 
under reduced pressure. Extracted fractions were designated 
as DPFC for D. pentagyna fraction from chloroform, DPFE 
for D. pentagyna fraction from ethyl acetate and DPFB for 
D. pentagyna fraction from n-butanol, respectively. These 
were subjected to further rigorous fractionation to remove 
impurities.
   All solvents were purchased from Sisco Research 
Laboratories, Fisher; silica gel for thin layer chromatography 
(TLC) and CC were purchased from Emerck; precoated TLC 
plates were purchased from Emerck; reverse phase column 
material (diaion HP 20) was purchased from Mitsubishi 
Chemicals. Glass columns were from Remco, India. Solvent 
removal under reduced pressure was done in Rotary 
evaporator (Stuart, UK). TLC spot detection was done either 
by iodine vapour or by an UV lamp of 254 nm (Merck, 
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1.12537.0001). 
   DP-47 was separated by 30% ethyl acetate (EtOAc) in CHCl3 
from CHCl3 extract DPFC (chloroform fraction) and is soluble 
in dimethylsulfoxide and methanol. DP-43 was isolated from 
EtOAc extract fractioned by 10% methanol in EtOAc (DPFE, 
ethyl acetate fraction) which is soluble in water. Butanol 
extract fractioned by water was the DP-50 which was 
isolated from DPFB (n-butanol fraction). 
2.2. Screening of antimicrobial activity 
   Several modifications were done in the antimicrobial assay 
method, though the Kirby-Bauer disk-diffusion method 
was followed. In the laboratory, specific bacterial strains 
were not available. A basal medium was used at a bacterial 
load 1.0 McFarland for initial screening of the antimicrobial 
activity. The fraction with superior antimicrobial potency 
displayed in the initial screening is further evaluated at 
higher microbial load (1.5 McFarland). Then a selective 
medium for enteric bacteria was used for final evaluation. 
All assays were done in triplicates and for standardization 
and uniformity the assay observations were plotted 
statistically.
2.2.1. Municipal sewage collection
   Domestic sewage samples were collected from urban 
Agartala Municipality in a sterile plastic container 
(50 mL) during July-August 2013. Sampling area was densely 
populated. Samples were normally taken at about one-third 
of the total depth below the surface of sewage water. Sewage 
sludge was avoided and the sample was translucent and 
somewhat turbid. Samples were transported within 2 h of 
collection to the microbiology lab for further study.
2.2.2. Microbial stock
   The sewage sample was transferred in a capped test tube 
and vortex mixed. Samples were cultured on nutrient agar 
slants as well as peptone water [peptone 10 g, NaCl 5 g/L, pH 
(7.2±0.2)]. Overnight grown cultures (37 °C) are used as stock 
for further study. 
2.2.3. Culture medium  
   Antimicrobial susceptibility on two different media 
platforms was analyzed. Initially, we used nutrient agar 
(Sisco Research Laboratories) as a basal media, while 
MacConkey ‘s agar (Himedia) was used as a selective media 
with the extract showing most potent antimicrobial activity 
in the screening.
  Nutrient agar (agar 15.0 g/L, peptone 5.0 g/L, NaCl 5.0 g/
L, yeast extract 2.0 g/L, beef extract 1.0 g/L) supports the 
growth of a variety of non-fastidious bacteria. On the other 
hand, MacConkey’s agar (peptic digest of animal tissue 20.0 
g/L, lactose 10.0 g/L, sodium taurocholate 5.0 g/L, nutral 
red 0.04 g/L, agar 20.0 g/L) is used for cultivation of various 
enteric bacteria. Supplementation of NaCl (5.0 g/L) will help 
to cultivate Vibrio sp. 2.8% (w/v) nutrient agar in distilled 
water was boiled gently with stirring in a round bottom flask 
over a heating mantle and subsequently autoclaved (15 psi at 
120 °C for 15 min). It was used for culturing the non-
fastidious bacteria and to maintain the stock. On the other 
hand, 5.5% (w/v) MacConkey’s agar was prepared similarly for 
the enteric bacteria. Another batch of 5.5% (w/v) MacConkey’s 
agar was supplemented with 0.5% (w/v) NaCl for Vibrio sp. 
2.2.4. Inoculum preparation
   A 1.0 McFarland standard was prepared by adding 1.0 mL 
of 1% BaCl2 to 99.0 mL of 1% H2SO4 and mixing thoroughly. 
The turbidity of 1.0 McFarland standard was matched to a 
bacterial suspension made in 4 mL sterile distil water from 
the stock culture. This results in a suspension containing 
approximately 2伊108 CFU/mL to 3伊108 CFU/mL of bacteria 
(for Escherichia coli ATCC 25922). To evaluate potency in 
an increased bacterial load, bacterial suspension of 1.5 
McFarland standard was used whereas for low bacterial load 
0.5 McFarland standard was used. 
2.2.5. Antimicrobial assay
   Kirby-Bauer disk-diffusion method with modifications was 
used to identify sensitivity to the various D. pentagyna plant 
extracts. Commercially acquired ciprofloxacin was dissolved 
in sterile distill water (100 mg/L) and filter paper disks of 6 
mm diameter and 0.4 mm thickness were impregnated with 
10 µL-50 µL of the solution by repeated cycles of saturation 
and warming (30 °C) in sterile condition. Similarly for the 
compounds under evaluation were used for impregnation 
of filter paper disk at various concentrations. Assay 
with ciprofloxacin was the positive control for our study.
   Culture medium (nutrient agar, MacConkey’s agar and 
NaCl supplemented MacConkey’s agar) were poured on 
standard Petri plates (for a depth of 4 mm approximately) in 
the sterile environment of laminar airflow. Dry plates were 
inoculated evenly and uniformly by bacterial suspension 1.0 
McFarland standard or any other as per need. Surface of the 
agar was streaked by a sterile cotton swab that is dipped into 
the adjusted suspension by rotating the plates at 60° each 
time to ensure an even distribution of inoculum. Standard 
antibiotic disk (positive control), solvent disk (negative 
control) and disks containing various concentrations of 
different plant compounds were subjected on already 
seeded plates. Seeded culture plates with filter paper disks 
were incubated at 37 °C for 24 h or for prolonged period in a 
laboratory incubator. Inhibition zones were measured by a 
pointed geometric compass and in millimeter scale.
2.2.6. Statistical analysis
   All assays were done in triplicates. Mean of the zone 
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of inhibition and the standard deviation were mentioned 
in the results. Since the plant fractions were in different 
dilutions, the standardization of the results was done by 
plotting the amount (in mg/disk) of standard antibiotic or 
the studied compound with the zone of inhibition (y-axis of 
the plot, mm) it produced. A regression line with slope and 
intercept (y=mx+c) of the plot indicate potency of the studied 
compound to form the zone of inhibition (mm). The x-axis 
(amount of inhibitor/disk) were formatted with the same 
maximum limit for standardizing the plot.
2.3. Urease inhibition assay  
   Inhibition of urease activity was studied using kinetic 
method by using urease/glutamate dehydrogenase (GLDH) 
system[23-25]. Using kinetic method urease/GLDH system 
is inhibited by urea analogues[26]. On the same principle, 
we studied in vitro urease inhibition in comparison to 
the standard inhibitor thiourea. However, the inhibition 
kinetics of the D. pentagyna fruit extracts may not follow the 
competitive inhibition and it remains to be studied.
   Initially commercial urease/GLDH system is calibrated 
by standard urea solution (50 mg/dL, 40 mg/dL). Urease 
(>6 000 IU/L) in a buffered environment (tris, pH 7.8) 
hydrolyses urea into NH4
+ (ammonium). The keto acid 
α-keto glutarate (7 mmol/L) in the presence of GLDH 
(>1 000 IU/L) converts into L-glutamate. The reducing 
equivalent is provided by reduced form of nicotinamide-
adenine dinucleotid (NADH) (0.25 mmol/L). The decrese in 
absorbance (at 340 nm) due to decrese in NADH concentration 
in unit time is proportional to formation of NH4
+ and thus 
indicated urease activity in a constant amount of urea. A 
semi automatic biochemistry analyzer (Sinnowa, Beacon 
3000-P) was used for the assay. A total of 10 µL urea 
(50 mg/dL or 40 mg/dL) or 10 µL mixture of 5 µL urea 
(50 mg/dL) and 5 µL water is reacted in different tubes with 
α-keto glutarate, urease/GLDH and NADH with delay time 
30 seconds and delta time 60 seconds at 37 °C. A decreasing 
slope of reaction and the concentration of urea (from A340) 
in the sample was given by the biochemistry analyzer. The 
concentration of urea has been measured by the activity of 
the urease presented in the reaction mixture and thus it is 
considered the standard urease activity.
   Urease inhibition was standardized by the presence of 
an inhibitor and this assay would show a decrese in the 
concentration of urea that already presented in the reaction. 
This assay was considered as the standard inhibition of the 
urease activity using a known inhibitor. The standard urease 
activity used 5 µL standard urea solution (50 mg/dL) and 5 µL 
solution of 1% thiourea in reaction tubes containing α-keto 
glutarate, urease/GLDH and NADH. Inhibition was calculated 
as:
   Inhibition (%)=[(100-Ui)/U]伊100
   Where Ui is concentration of urea (mg/dL, A340) in the 
presence of inhibitor 1% thiourea (5 µL) and U is the 
concentration of urea (mg/dL, A340) without the inhibitor (5 µL 
water).
   For the urease inhibition study of D. pentagyna fraction, 
two dilutions of the extract in 5 µL each was present in 
the reaction mixture with 5 µL of urea standard solution 
(50 mg/dL). Urease inhibition of the D. pentagyna fraction 
was calculated as: 
   Inhibition (%)=[(100-Udp)/U]伊100 
   Where Udp is concentration of urea (mg/dL, A340) in the 
presence of the D. pentagyna fraction in a particular dilution 
(5 µL) and U is concentration of urea (mg/dL, A340) without the 
D. pentagyna fraction (5 µL water).
3. Results
   Preliminary screening of the D. pentagyna successfully 
identified the most potent fraction among the studied 
extracts. 
D. pentagyna Roxb. fruit
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Figure 1. Schematic representation of the pipeline for screening of in vitro 
anti-enteritic properties of D. pentagyna Roxb. fruit extracts.
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   The steps involved in the screening regime and critical 
results have been summarized schematically in Figure 1. 
The pipeline described here can be followed for preliminary 
screening of phytochemicals in other similar type studies. 
Column charts have been used to compare values (slopes in 
the linear plots of amount in mg vs. zone of inhibition in mm 
and percentage of urease inhibition) across categories such 
as antimicrobial assays and urease inhibition assays. Various 
fractions of the plant extract were in dilutions. Therefore, 
the results of the antimicrobial assays were standardized 
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using linear equations for uniformity. In Figure 1, the upper 
graph describes the initial antimicrobial assessment of 
various fractions. Slopes resulted from linear equations 
(y=mx+c, where x axis=amount of antimicrobial in mg; y 
axis=diameter of clear zone in mm) of antimicrobial assays 
were compared. The antimicrobial assay of ciprofloxacin 
antibiotic was taken as standard. Very high potency of the 
standard drug is seen. Among D. pentagyna Roxb. fruit 
extracts the water soluble fraction of butanol extract, i.e. 
DP-50 showed highest potency and therefore it was further 
evaluated in vitro.
   Evaluation of antimicrobial potency of DP-50 was done in 
three different culture conditions (with different bacterial 
load) and the lower part of Figure 1 (left hand side) 
describes this by graphical representation. In this graph, 
the slopes (resulted from linear equations) of antimicrobial 
assays in three different culture conditions were shown. 
Lower right hand side graph compares the percentage of 
urease inhibition by DP-50 and standard inhibitor (1% 
thiourea). Results in detail are described in following 
sections.
3.1. Antimicrobial activity assay
3.1.1. Standard inhibition 
   Standard inhibition of the stock bacteria by ciprofloxacin 
(100 mg/L) in nutrient agar media (1.0 McFarland) after 
24 h incubation was observed (Table 1). Similar culture 
condition and seed stock was maintained for the assays 
of plant extracts. The assay of ciprofloxacin inhibition 
zone was for comparing the potency of various fractions 
against similar microflora cultured in similar conditions. 
Ciprofloxacin assay was taken as the positive control.
Table 1
Zone of inhibition with positive control ciprofloxacin in nutrient agar against sewage 
microflora (1.0 McFarland) after 24 h incubation.
Sl No. of disk Amount of ciprofloxacin 
standard solution (µg)
Amount of 
ciprofloxacin (mg)
Zone of inhibition 
(mm)
1 1.0 0.001 0   8依0
2 2.5 0.002 5 17依0
3 4.0 0.004 0 20依0
4 5.0 0.005 0 26依0
Ciprofloxacin standard solution (100 mg/L) was added as 10 µL and its multipliers in the 
disks.
   Upto 15 µg of ciprofloxacin was added per disk and 
standard plot with slope showed high antimicrobial 
potential of the standard drug (Figure 2). In this Figure, the 
x-axis represents the amount of ciprofloxacin/disk (µg). The 
x-axis is extended upto 15 mg or 15 000 µg for uniformity 
with other assay statistics. The amount of ciprofloxacin per 
disk were in minuscule and therefore the points merged 
together, however, the amounts of ciprofloxacin per disk 
(mg) and zone of inhibition they produced (mm) are shown 
in Figure 2.
30
25
20
15
10
5
0
Z
on
e 
of
 in
hi
bi
ti
on
 (m
m
)
0     1 000   2 000  3 000  4 000  5 000   6 000  7 000   8 000   9 000  1 0000  11 000  12 000  13 000  14 000  15 000  
0.0050 mg; 26 mm
y=4204.x+4.612
Amount of ciprofloxacin/disk  (µg)
0.0040 mg; 20 mm
0.0025 mg; 17 mm
0.0010 mg; 8 mm
Figure 2. Positive control of ciprofloxacin for zone of inhibition in nutrient 
agar with the sewage culture seed stock (1.0 McFarland) after 24 h incubation. 
Linear plot of zone of inhibition (mm) vs. amount of ciprofloxacin/disk (µg).
3.1.2. Antimicrobial activity of DP-47
   DP-47 was isolated from chloroform extract of D. 
pentagyna fruit by column chromatography with 30% ethyl 
acetate in chloroform. It is soluble in dimethylsulfoxide 
(DMSO) as well as in methanol. Initial screening DP-47 in 
DMSO was done at a dilution of 50 mg of DP-47 dissolved in 
150 µL DMSO (Table 2). 
Table 2
Initial screening of antimicrobial activity for DP-47 (in DMSO) in nutrient agar against 
sewage microflora (1.0 McFarland) after 24 h incubation.
Sl No. of disk Volume of DP-47 (µL) Amount of DP-47 (mg) Zone of inhibition (mm)
1 10.0 3.33伊1  7.0依0.1
2 20.0 3.33伊2  8.0依0.2
3 30.0 3.33伊3  9.0依0.2
4 40.0 3.33伊4 10.0依0.2
   Similarly initial screening of DP-47 in MeOH was done 
at a dilution of 20 mg of DP-47 dissolved in 100 µL MeOH 
(Table 3). Zone of inhibition was observed using the same 
parameters of culture. 
Table 3
Initial screening of antimicrobial activity for DP-47 (in MeOH) in nutrient agar against 
sewage microflora (1.0 McFarland) after 24 h incubation.
Sl No. of disk Volume of DP-47 (µL) Amount of DP-47 (mg) Zone of inhibition (mm)
1 10.0 2.00伊1 10.0依0.0
2 20.0 2.00伊2 11.0依0.1
3 30.0 2.00伊3 11.5依0.2
4 40.0 2.00伊4 12.0依1.0
   It seemed that DP-47 had more potent antimicrobial 
activity when in a dilution with MeOH as observed from 
the initial screening of the first four disks (Tables 2 and 
3). Therefore, the amount of DP-47 in MeOH per disk was 
increased and the antimicrobial activity and plotted the 
results (Table 4) in a standard xy graph (Figure 3).
Table 4
Zone of inhibition of DP-47 (in MeOH) at higher concentration in nutrient agar against 
sewage microflora (1.0 McFarland) after 24 h incubation.
Sl No. of disk Volume of DP-47 (µL) Amount of DP-47 (mg) Zone of inhibition (mm)
4 40.0 2.00伊4 12.0依1.0
5 50.0 2.00伊5 15.0依0.0
6 60.0 2.00伊6 17.0依0.1
7 70.0 2.00伊7 19.0依0.0
   The plots (Figures 3 and 4) showed that the DP-47 fraction 
in methanol have slightly higher antimicrobial activity (y= 
0.758x+7.571) than DP-47 in DMSO (y=0.300x+6.000).
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Figure 3. Antimicrobial potency of DP-47 in DMSO.
Zone of inhibition (mm) of DP-47 (in DMSO) vs. amount of DP-47 (mg/disk) in 
nutrient agar against sewage microflora (1.0 McFarland) after 24 h incubation.
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Figure 4. Antimicrobial potency of DP-47 in MeOH.
Zone of inhibition (mm) of DP-47 (in MeOH) vs. amount of DP-47 (mg/disk) in 
nutrient agar against sewage microflora (1.0 McFarland) after 24 h incubation.
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3.1.3. Antimicrobial activity of DP-43
   The fraction was soluble in water and was isolated from 
the initial fraction DPFE. An initial screening of DP-43 at 
a dilution of 20 mg in 200 µL water showed good results 
and inhibition zones up to (15依0) mm were achieved with 
4 mg/disk (Table 5). Further analysis at a higher amount 
showed further antimicrobial activity (Table 6). The standard 
plot clearly indicates that DP-43 in water was better than 
DP-47 in terms of antimicrobial action (Figures 4 and 5).
Table 5 
Initial screening of antimicrobial activity for DP-43 (in water) in nutrient agar against 
sewage microflora (1.0 McFarland) after 24 h incubation.
Sl No. of disk Volume of DP-43 (µL) Amount of DP-43 (mg) Zone of inhibition (mm)
1 10.0 1.00伊1 10依0
2 20.0 2.00伊1 11依0
3 30.0 3.00伊1 12依0
4 40.0 4.00伊1 15依0
Table 6
Zone of inhibition of DP-43 (in water) at higher concentration in nutrient agar against 
sewage microflora (1.0 McFarland) after 24 h incubation.
Sl No. of disk Volume of DP-43 (µL) Amount of DP-43 (mg) Zone of inhibition (mm)
4 40.0 1.00伊4 14.5依0.15
5 50.0 1.00伊5 16.0依0.10
6 60.0 1.00伊6 17.0依0.50
7 70.0 1.00伊7 18.0依0.10
3.1.4. Antimicrobial activity of DP-50
   In the initial screening, DP-50 showed superior 
antimicrobial activity in comparison to any other fractions 
(Table 7 and Figure 6). This fraction was analyzed in different 
bacterial load as well as in different culture mediums with 
the dilution of 20 mg of DP-50 in 150 µL water.
   High antimicrobial potential of DP-50 as showed in the 
initial screening prompted us to increase the antimicrobial 
load to 1.5 McFarland as well the amount of DP-50 per disk 
using the same dilution of the sample (Table 8). 
Figure 5. Antimicrobial potency of DP-43 in water.
Zone of inhibition (mm) of DP-43 (in water) vs. amount of DP-43 (mg/disk) in 
nutrient agar against sewage microflora (1.0 McFarland) after 24 h incubation.
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Table 7 
Initial screening of antimicrobial activity for DP-50 (in water) in nutrient agar against 
sewage microflora (1.0 McFarland) after 24 h incubation.
Sl No. of disk Volume of DP-50 (µL) Amount of DP-50 (mg) Zone of inhibition (mm)
1 10.0 1.30伊1  7依0
2 20.0 1.30伊2 10依0
3 30.0 1.30伊3 15依0
4 40.0 1.30伊4 20依0
Figure 6. Antimicrobial potency of DP-50 (in water).
Zone of inhibition (mm) of DP-50 (in water) vs. amount of DP-50 (mg/disk) in 
nutrient agar against sewage microflora (1.0 McFarland) after 24 h incubation.
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Table 8 
Evaluation of antimicrobial activity for DP-50 (in water) at higher concentration and 
increased bacterial load. 
Sl No. of disk Volume of DP-50 (µL) Amount of DP-50 (mg) Zone of inhibition (mm)
1 40.0 1.30伊4 11.0依0.0
2 50.0 1.30伊5 13.0依0.1
3 60.0 1.30伊6 15.0依0.1
4 70.0 1.30伊7 17.0依0.2
Observed in nutrient agar against sewage microflora (1.5 McFarland) after 24 h 
incubation.
   In increased bacterial load, DP-50 was a potent 
antimicrobial agent (Figure 7). At lower microbial load i.e. 
at 0.5 McFarland, DP-50 showed complete inhibition of any 
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vegetative growth in nutrient agar after 24 h of incubation. 
No bacterial growth was observed in the culture plates 
(photograph of a assay plate given in Figure 8).
   In order to evaluate antimicrobial activity of DP-
50 in selective condition, growth of coliforms, assays in 
MacConkey’s agar (Table 9) were performed.
Table 9
Evaluation of antimicrobial activity for DP-50 (in water) in MacConkey’s agar against 
sewage microflora (1.0 McFarland) after 24 h incubation.
Sl No. of disk Volume of DP-50 (µL) Amount of DP-50 (mg) Zone of inhibition (mm)
1 10.0 1.30伊1 9.0依0.0
2 20.0 1.30伊2 10.0依0.1
3 30.0 1.30伊3 12.0依0.2
4 40.0 1.30伊4 13.0依0.2
   The assay showed satisfactory antimicrobial potential 
(y=1.076x+7.500) of DP-50 in MacConkey’s agar against 
sewage microflora (1.0 McFarland) (Figure 9).
Figure 7. Antimicrobial potency of DP-50 at higher bacterial load.
Zone of inhibition (mm) of DP-50 (in water) vs. amount of DP-50 (mg/disk) in 
nutrient agar against sewage microflora (1.5 McFarland) after 24 h incubation.
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Figure 8. Antimicrobial activity of different fractions extracted from D. pentagyna at differnt concenrations.
A: Standard inhibition of stock bacteria from municipal sewage by ciprofloxacin (100 mg/L) in nutrient agar (1.0 McFarland), 24 h incubation; B: Initial screening 
of DP-47. DP-47 (50 mg) was dissolved in 150 µL DMSO to make a saturated solution. Disk containing 10-40 µL of DP-47 is shown on nutrient agar plate (1.0 
McFarland), 24 h incubation; C: A nutrient agar plate (1.0 McFarland) showing inhibition zones with DP-47. A total of 20 mg DP-47, was dissolved in 100 µL 
MeOH to make a saturated solution. Disk containing 10-40 µL of DP-47, 24 h incubation; D: A nutrient agar plate (1.0 McFarland) showing inhibition zones 
with DP-47. A total of 20 mg DP-47 was dissolved in 100 µL MeOH to make a saturated solution. Disk containing 40-70 µL of DP-47, 24 h incubation. E: A 
nutrient agar plate (1.0 McFarland) showing intinal screening of DP-43. A total of 20 mg was dissolved in 150 µL water. Disk containing 10-40 µL of DP-50 (1.0 
McFarland), 24 h incubation;F: A nutrient agar plate (1.0 McFarland) showing intinal screening of DP-50. A total of 20 mg was dissolved in 200 µL water. Disk 
containing 10-40 µL of DP-43 (1.0 McFarland), 24 h incubation; G: A nutrient agar plate (1.0 McFarland) showing intinal screening of DP-43. A total of 20 mg 
was dissolved in 200 µL water. Disk containing 40-70 µL of DP-43 (1.0 McFarland), 24 h incubation; H: Evaluation of antimicrobial potency of DP-50 at higher 
bacterial load (1.5 McFarland) of municipal sewage microflor, a nutrient agar plate showing intinal screening of DP-50. A total of 20 mg was dissolved in 150 µL 
water. Disk containing 40-70 µL of DP-50, 24 h incubation; I: Evaluation of antimicrobial potency of DP-50  in low bacterial load (0.5 McFarland) of municipal 
sewage microflor, a nutrient agar plate showing intinal screening of DP-50. A total of 20 mg was dissolved in 150 µL water. Disk containing 10-40 µL of DP-
50,  24 h incubation; J: Evaluation of antimicrobial potency of DP-50 on MacConkey ‘s agar supplemented with 5.0 g/L NaCl (1.0 McFarland). A total of 20 mg 
DP-50 was dissolved in 150 µL water. Disk containing 10-40 µL of DP-50, 24 h incubation; K: Evaluation of antimicrobial potency of DP-50 on MacConkey‘s 
agar (1.0 McFarland). A total of 20 mg DP-50 was dissolved in 150 µL water. Disk containing 10-40 µL of DP-50. Clear zones of inhibition are seen on the disks 
after 24 h. After 72 h of prolonged incubation in the prence of DP-50, round translucent colonies are seen around a larger zone than that of the most clear zone 
of inhibition; L: Violet colored rod shaped Gram-positive bacilli isolated from nutrient agar stock culture of the sewage sample  micro-flora. [Observed under 
伊100 (oil immersion)]; M: Pink red  colored  rod shaped Gram-nagetive  bacilli isolated from MacConkey‘s agar culture of the sewage sample  micro-flora. 
[Observed under 伊100 (oil immersion)]. 
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Figure 9. Antimicrobial potency of DP-50 in a selective media. 
Zone of inhibition (mm) of DP-50 (in water) vs. amount of DP-50 (mg/disk) 
in MacConkey’s agar against sewage microflora (1.0 McFarland) after 24 h 
incubation.
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   Moreover, MacConkey’s agar supplemented with 5% NaCl 
was also used for the evaluation of antimicrobial potency of 
DP-50 in a selective medium (Table 10).
Table 10
Evaluation of antimicrobial activity for DP-50 (in water) in MacConkey’s agar 
supplemented with 5% NaCl against sewage microflora (1.0 McFarland) after 24 h 
incubation.
Sl No. of disk Volume of DP-50 
(µL)
Amount of DP-50 
(mg)
Zone of inhibition 
(mm)
1 10.0 1.3伊1 8依0
2 20.0 1.3伊2 9依0
3 30.0 1.3伊3 11依0
4 40.0 1.3伊4 13依0
   DP-50 was an effective antimicrobial in this selective 
medium and seemed to have a good potential to control 
bacterial infection (Figure 10).
Figure 10. Antimicrobial potency of DP-50 in a selective media.
Zone of inhibition (mm) of DP-50 (in water) vs. amount of DP-50 (mg)/disk in 
MacConkey’s agar supplemented with 5% NaCl against sewage microflora (1.0 
McFarland) after 24 h incubation.
26
21
16
11
6
1
-4
Z
on
e 
of
 in
hi
bi
ti
on
 (m
m
)
0                                5                                10                               15
Amount of DP-50 (mg/disk)
DP-50 was dissolved in water
y=1.307x+6.000
   The above results showed that DP-50 was a superior 
quality antimicrobial agent that had potency against 
sewage microflora including a possible pathogenic load 
of coliforms as well as Vibrios. Moreover, the prolonged 
culture of pathogens (>72 h) in MacConkey’s agar with DP-50 
showed that no colonies developed in proximity to the disks 
containing DP-50 (a culture plate was showed in Figure 8). 
This indicated that the pathogens might not readily develop 
resistance against the active ingredients in the DP-50 
fraction. Since specific bacterial strains that are generally 
used for this kind of antimicrobial assay were not used 
in this study due to the unavailability that we have opted 
for a thorough evaluation using different culture methods. 
The potential antimicrobial activity of DP-50 was further 
subjected to analysis with respect to in vitro urease enzyme 
inhibition assay. Representative photographs of culture 
plates for each batch of antimicrobial susceptibility assays 
are given in Figure 8.
3.2. Urease inhibition assay
   Calibration of the kinetic method for in vitro urease assay 
with the urea standard solutions (S1 and S2) showed sufficient 
sensitivity (Table 11). Urease activity in our assay method 
was inhibited to 33.914% by competitive inhibitor thiourea 
(1% solution) (Table 12). The most potent antimicrobial 
fraction DP-50 was assayed at two different dilutions for the 
evaluation of urease inhibition activity. At a lower dilution 
(20 mg was dissolved in 150 µL water) DP-50 was a highly 
potent urease inhibitor and inhibited 94.87% of the urease 
activity (Table 13). However, at a higher dilution (10 mg was 
dissolved in 5 mL water) only 15.35% urease activity was 
inhibited.
Table 11
Calibration of urea estimation by kinetic method (urease>6 000 IU/L and 
GLDH>1 000 IU/L).
Standard urea solution Distill water Concentration of urea 
(mg/dL) (from A340)
S1 10 µL - 51.927 3依1.360 0
 5 µL 5 µL 27.292 0依1.600 0
S2 10 µL - 39.445 5依0.392 0
 5 µL 5 µL 24.860 0依3.400 0
S1: 50 mg/dL urea solution; S2: 40 mg/dL urea solution.
Table 12 
Urease inhibition by standard inhibitor thiourea (1% thiourea, 1 mg/dL) 
(urease>6 000 IU/L and GLDH>1 000 IU/L).
Standard urea  
solution (50 mg/dL) 
Standard inhibitor Distill 
water
Concentration of urea (mg/
dL) (from A340) 
Inhibition 
(%)
5 µL 5 µL - Ui=18.0360依1.0
33.914%
5 µL - 5 µL U=27.2920依1.6
Ui: with inhibitor Ui;  U: with water U.
Table 13
Urease inhibition by DP-50 at low and high concentration (dilutions in water) 
(urease>6 000 IU/L and GLDH>1 000 IU/L).
Standard urea 
solution 
(50 mg/dL) 
DP-50 Distill 
water
Concentration of urea 
(mg/dL) (from A340) 
Inhibition (%)
20 mg was 
dissolved in 
150 µL water
10 mg was 
dissolved in 
5 mL water
5 µL 5 µL - -  Udp=1.400 0依3.0 94.87%
15.35%
5 µL - 5 µL U=27.292 0依1.6
5 µL - 5 µL -    Udp=23.100 0依1.0
Udp: with inhibitor Udp;  U: with water U.
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4. Discussion
   The tropics as a whole is a biodiversity super hotspot. 
There is an enormous variety of therapeutically important 
plant resources in the region. Also this is the region where 
diverse populations of pathogenic organisms flourish cause 
infections and lead to huge mortality. In this region, the 
traditional knowledge of medicinal plants have helped to 
tackle several of these infective agents to a large extent. 
It was estimated that about 80% of the world’s inhabitants 
relyed mainly on traditional medicines for their primary 
health care[27]. Moreover, several of the modern blockbuster 
drugs have been isolated from natural sources that were 
used in traditional medicine[28]. Therefore, the traditionally 
used plants may be the source of future drugs which will be 
used to more effectively treat on the existing infections or 
the new pathogenic threats as resistant infective strains.
   D. pentagyna has been used as a traditional herb to 
address enteric infection like dysentery. We have explored 
the possibility to use various fractions of photochemicals 
isolated from its fruits against enteric infections. Since 
municipal sewage is a source of gastrointestinal pathogens, 
we culture bacteria sourced from municipal sewage and 
observe antimicrobial potential of D. pentagyna fruit 
extracts. The fraction of DP-47 from the chloroform extract 
of D. pentagyna fruit showed better antimicrobial potential 
in MeOH than in DMSO with a higher slope (y=0.758x+7.571 
in MeOH v.s. y=0.300x+6.000 in DMSO) in the disk diffusion 
assay. The fraction of DP-43 from ethyl acetate extract had 
better potency (y=1.428x+8.392) than DP-47. The fraction of 
DP-50 from n-butanol was the most potent antimicrobial 
as evident from its highest slope (y=3.384x+2.000) in a zone 
of inhibition v.s. amount of fraction per disk plot. The 
antimicrobial assay for all three fractions (DP-47, DP-43 
and DP-50) was performed in a basal medium nutrient agar 
with a standard bacterial load of 1.0 McFarland and all three 
fractions may be effective against a variety of non-fastidious 
bacteria with different potencies.
   Since DP-50 demonstrated higher antimicrobial activity, 
we evaluated its potency in a higher bacterial load of 1.5 
McFarland. It was observed that DP-50 was even active 
in this condition. Therefore, it was clear that the active 
ingredients presented in DP-50 fraction may be able to 
tackle severe infection caused by a heavy inoculum of 
infective bacteria.
   When DP-50 was assayed in MacConkey’s agar with or 
without 5% NaCl supplementation, it showed antimicrobial 
activity. MacConkey’s agar promoted selective growth of 
coliforms, an established enteric pathogen group. The 
potency of DP-50 to inhibit coliforms was found satisfactory 
(y=1.076x+7.500). In antimicrobial assay of DP-50 in 
MacConkey’s agar with 5% NaCl the extract showed good 
potency (y=1.307x+6.000) which indicated that DP-50 may 
even be effective agaist Vibrio infections. Therefore, DP-
50 may be considered as a potent antimicrobial against a 
variety of enteric pathogens. 
   Moreover, in prolonged incubation of DP-50 disks in 
assays containing enteric pathogens in MacConkey’s agar, no 
colonies were formed in the proximity to the disks after 72 h. 
This indicated that resistance against the active ingredients 
of DP-50 would not occur readily. As we know, some of the 
countries are epicenters of resistance in pathogenic bacteria 
and we need effective therapy to address the issue of drug 
resistance[3]. In this regard, DP-50 may provide a successful 
therapeutic intervention to embark upon drug resistance 
coliforms.
   We also observed satisfactory urease inhibition by DP-50 
in in vitro kinetic assay and this clearly demonstrated that 
DP-50 may even address H. pylory colonization in stomach. 
This was a significant observation in terms of gastrointestinal 
infections with respect to the tropical region. There are 
existing therapy against H. pylory, a Class I carcinogen 
(World Health Organizaioin) such as phosphorodiamidates, 
hydroxamic acid derivatives, imidazoles, salicylic acid 
derivatives and various proton pump inhibitors like 
pentaprazole, omeprazole, etc. All these therapies have 
their share of drawbacks such as toxicity, side effects, low 
bioavailability and higher costs. Therefore, DP-50, a natural 
product from D. pentagyna Roxb. fruit extracts may be an 
excellent source of active pharmaceutical ingredients with 
low toxicity, low side effects, etc. 
   In conclusion, it may be said that the traditional use of 
the herb D. pentagyna Roxb. to treat dysentery is rather 
justified and the active ingredients of DP-50 could be a good 
source of antimicrobial agents against a variety of enteric 
pathogens and H. pylory infections. The graphical abstract 
demonstrates this work in a concise way. From the results of 
the rigorous study on D. pentagyna Roxb. fruit extracts, we 
are certain that there are active ingredients in the fractions 
that drive a potential antimicrobial activity. The ingredients 
may be active as a pure compound or may have synergistic 
effect to bring about the significant biological function. 
   After this initial study, we shall be focusing on the DP-
50 fraction and isolate compounds in pure form and their 
structure will be deduced. Compounds will be assayed 
against specific enteric pathogen strains to determine MIC 
and IC50. For similar studies, H. pylory clinical isolates 
from gastric biopsy will also be used. We shall be able to 
infer if any synergistic effect is present or not. Structures 
with similar pharmacophores will be analysed by 3D-QSAR 
using IC50/MIC values and the resultant molecule may be 
synthesized and analyzed further by in vitro techniques. 
Compound/s with best IC50/MIC value against H. pylory or the 
designed pharmacophore resultant from 3D-QSAR will be 
studied in silico. Quantum polarized docking simulations 
of the compound structure/s with the H. pylory urease (PDB 
models for H. pylory urease such as 2WGL. pdb, 1E9Z. pdb, 
etc.), a Ni-bound metalloenzyme will further give vital 
insight about the isolated compound/s and its interactions. 
A computational ADMET prediction followed by in vivo trials 
will build the platform for formulation of a therapeutic drug 
against various enteric pathogens including H. pylory.
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